Understanding the cellular mechanisms of how neurons deal with aberrant proteins and the development of therapeutic strategies for neurodegenerative diseases. Specifically, I am interested in how a unique class of ubiquitin ligases recognizes misfolded glycoproteins and targets these aberrant proteins for destruction by the ubiquitin-proteasome pathway.